nach oben

Current Diabetes Reports

Erschienen in:

01.09.2017 | Hospital Management of Diabetes (A Wallia and JJ Seley, Section Editors)

How Low Can You Go? Reducing Rates of Hypoglycemia in the Non-critical Care Hospital Setting

verfasst von: Kristen Kulasa, Patricia Juang

Erschienen in: Current Diabetes Reports | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

The purpose of this review is to discuss strategies to reduce rates of hypoglycemia in the non-critical care setting.

Recent Findings

Strategies to reduce hypoglycemia rates should focus on the most common causes of iatrogenic hypoglycemia. Creating a standardized insulin order set with built-in clinical decision support can help reduce rates of hypoglycemia. Coordination of blood glucose monitoring, meal tray delivery, and insulin administration is an important and challenging task. Protocols and processes should be in place to deal with interruptions in nutrition to minimize risk of hypoglycemia. A glucose management page that has all the pertinent information summarized in one page allows for active surveillance and quick identification of patients who may be at risk of hypoglycemia. Finally, education of prescribers, nurses, food and nutrition services, and patients is important so that every member of the healthcare team can work together to prevent hypoglycemia.

Summary

By implementing strategies to reduce hypoglycemia, we hope to lower rates of adverse events and improve quality of care while also reducing hospital costs. Future research should focus on the impact of an overall reduction in hypoglycemia to determine whether the expected benefits are achieved.

Turchin A, Matheny ME, Shubina M, Scanlon JV, Greenwood B, Pendergrass ML. Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward. Diabetes Care. 2009;32(7):1153–7.CrossRefPubMedPubMedCentral

Garg R, Hurwitz S, Turchin A, Trivedi A. Hypoglycemia, with or without insulin therapy, is associated with increased mortality among hospitalized patients. Diabetes Care. 2013;36(5):1107–10.CrossRefPubMedPubMedCentral

Brodovicz KG, Mehta V, Zhang Q, Zhao C, Davies MJ, Chen J, et al. Association between hypoglycemia and inpatient mortality and length of hospital stay in hospitalized, insulin-treated patients. Curr Med Res Opin. 2013;29(2):101–7.CrossRefPubMed

Nirantharakumar K, Marshall T, Hodson J, Narendran P, Deeks J, Coleman JJ, et al. Hypoglycemia in non-diabetic in-patients: clinical or criminal? PLoS One. 2012;7(7):e40384.CrossRefPubMedPubMedCentral

• Milligan PE, Bocox MC, Pratt E, Hoehner CM, Krettek JE, Dunagan WC. Multifaceted approach to reducing occurrence of severe hypoglycemia in a large healthcare system. Am J Health Syst Pharm. 2015;72(19):1631–41. This article provides a great example of how one hospital system was able to significantly reduce severe hypoglycemia across 11 hospitals using many of the approaches mentioned in this paper.CrossRefPubMed

Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283–97.CrossRefPubMed

Classen DC, Jaser L, Budnitz DS. Adverse drug events among hospitalized Medicare patients: epidemiology and national estimates from a new approach to surveillance. Jt Comm J Qual Patient Saf. 2010;36(1):12–21.CrossRefPubMed

Analytics) PATH, Analytics) WLTH, (AHRQ) SC. Costs for Hospital Stays in the United States Rockville, MD2011.

Classen DC, Resar R, Griffin F, Federico F, Frankel T, Kimmel N, et al. ‘Global trigger tool’ shows that adverse events in hospitals may be ten times greater than previously measured. Health Aff (Millwood). 2011;30(4):581–9.CrossRef

10.

Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract. 2009;15(4):353–69.CrossRefPubMed

11.

Curkendall SM, Natoli JL, Alexander CM, Nathanson BH, Haidar T, Dubois RW. Economic and clinical impact of inpatient diabetic hypoglycemia. Endocr Pract. 2009;15(4):302–12.CrossRefPubMed

12.

Carey M, Boucai L, Zonszein J. Impact of hypoglycemia in hospitalized patients. Curr Diab Rep. 2013;13(1):107–13.CrossRefPubMed

13.

Brutsaert E, Carey M, Zonszein J. The clinical impact of inpatient hypoglycemia. J Diabetes Complicat. 2014;28(4):565–72.CrossRefPubMed

14.

Varghese P, Gleason V, Sorokin R, Senholzi C, Jabbour S, Gottlieb JE. Hypoglycemia in hospitalized patients treated with antihyperglycemic agents. J Hosp Med. 2007;2(4):234–40.CrossRefPubMed

15.

Michota F, Braithwaite SS. Avoiding complications in the hospitalized patient: the case for tight glycemic control. J Hosp Med. 2007;2(Suppl 1):1–4.CrossRefPubMed

16.

Dendy JA, Chockalingam V, Tirumalasetty NN, Dornelles A, Blonde L, Bolton PM, et al. Identifying risk factors for severe hypoglycemia in hospitalized patients with diabetes. Endocr Pract. 2014;20(10):1051–6.CrossRefPubMed

17.

American Diabetes Association. Glycemic targets. Sec 6. In Standards of Medical Care in Diabetes—2017. Diabetes Care. 2017;40(Suppl. 1):S48–56.CrossRef

18.

Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. 2013;36(5):1384–95.CrossRefPubMedPubMedCentral

19.

Cook CB, Elias B, Kongable GL, Potter DJ, Shepherd KM, McMahon D. Diabetes and hyperglycemia quality improvement efforts in hospitals in the United States: current status, practice variation, and barriers to implementation. Endocr Pract. 2010;16(2):219–30.CrossRefPubMed

20.

Goldberg PA, Bozzo JE, Thomas PG, Mesmer MM, Sakharova OV, Radford MJ, et al. “Glucometrics”—assessing the quality of inpatient glucose management. Diabetes Technol Ther. 2006;8(5):560–9.CrossRefPubMed

21.

Schnipper JL, Magee M, Larsen K, Inzucchi SE, Maynard G. Society of Hospital Medicine Glycemic Control Task Force summary: practical recommendations for assessing the impact of glycemic control efforts. J Hosp Med. 2008;3(5 Suppl):66–75.CrossRefPubMed

22.

Maynard GA, Childers D, Holdych J, Kendall H, Hoag T, Harrison K. Improving glycemic control safely in non-critical care patients: a collaborative systems approach in nine hospitals. Jt Comm J Qual Patient Saf. 2017;43(4):179–88.CrossRefPubMed

23.

• The Glycemic Control Implementation Guide: Improving glycemic control, preventing hypoglycemia and optimizing care of the inpatient with hyperglycemia and diabetes: Society of Hospital Medicine; 2015 [second:[Available from: http://tools.hospitalmedicine.org/resource_rooms/imp_guides/GC/GC_Workbook.pdf. This guide contains step by step instructions on how to implement quality improvement strategies to improve inpatient glycemic control and reduce hypoglycemia.

24.

Boyd JC, Bruns DE. Quality specifications for glucose meters: assessment by simulation modeling of errors in insulin dose. Clin Chem. 2001;47(2):209–14.PubMed

25.

Blood glucose monitoring test systems for prescription point-of-care use: guidance for industry and food and drug administration staff [Internet]. 2016.

26.

Klonoff DC, Draznin B, Drincic A, Dungan K, Gianchandani R, Inzucchi SE, et al. PRIDE statement on the need for a moratorium on the CMS plan to cite hospitals for performing point-of-care capillary blood glucose monitoring on critically ill patients. J Clin Endocrinol Metab. 2015;100(10):3607–12.CrossRefPubMed

27.

Gomez AM, Umpierrez GE, Munoz OM, Herrera F, Rubio C, Aschner P, et al. Continuous glucose monitoring versus capillary point-of-care testing for inpatient glycemic control in type 2 diabetes patients hospitalized in the general ward and treated with a basal bolus insulin regimen. J Diabetes Sci Technol. 2015;10(2):325–9.CrossRefPubMedPubMedCentral

28.

Aloi J, Bode BW, Ullal J, Chidester P, McFarland RS, Bedingfield AE, et al. Comparison of an electronic glycemic management system versus provider-managed subcutaneous basal bolus insulin therapy in the hospital setting. J Diabetes Sci Technol. 2016;

29.

CMS/The Joint Commission. NQF-endorsed voluntary consensus standards for hospital care. Surgical care improvement project. 2014.

30.

Maynard G, Schnipper JL, Messler J, Ramos P, Kulasa K, Nolan A, et al. Design and implementation of a web-based reporting and benchmarking center for inpatient glucometrics. J Diabetes Sci Technol. 2014;8(4):630–40.CrossRefPubMedPubMedCentral

31.

Department of Health and Human Services. National Action Plan for Adverse Drug Event Prevention. 2014. [Available from: www.health.gov/hai/ pdfs/ADE-Action-Plan-508c.pdf.

32.

Centers for Medicare and Medicaid Services CMS Special Innovation Project: Maintenance and Development of Medication Measures. 2013 [Available from: https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/MMS/Downloads/FMQAI-Glycemic-Control-Measures-Public-Comment.pdf.

33.

Maynard G, Kulasa K, Ramos P, Childers D, Clay B, Sebasky M, et al. Impact of a hypoglycemia reduction bundle and a systems approach to inpatient glycemic management. Endocr Pract. 2015;21(4):355–67.CrossRefPubMed

34.

Sinha Gregory N, Seley JJ, Gerber LM, Tang C, Brillon D. Decreased rates of hypoglycemia following implementation of a comprehensive computerized insulin order set and titration algorithm in the inpatient setting. Hosp Pract (1995). 2016;44(5):260–5.CrossRef

35.

Fischer KF, Lees JA, Newman JH. Hypoglycemia in hospitalized patients. Causes and outcomes. N Engl J Med. 1986;315(20):1245–50.CrossRefPubMed

36.

Matyka K, Evans M, Lomas J, Cranston I, Macdonald I, Amiel SA. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care. 1997;20(2):135–41.CrossRefPubMed

37.

Moen MF, Zhan M, Hsu VD, Walker LD, Einhorn LM, Seliger SL, et al. Frequency of hypoglycemia and its significance in chronic kidney disease. Clin J Am Soc Nephrol. 2009;4(6):1121–7.CrossRefPubMedPubMedCentral

38.

Gianchandani RY, Neupane S, Iyengar JJ, Heung M. Pathophysiology and management of hypoglycemia in end stage renal disease patients—a review. Endocr Pract. 2016;

39.

Arem R. Hypoglycemia associated with renal failure. Endocrinol Metab Clin N Am. 1989;18(1):103–21.

40.

Mak RH. Impact of end-stage renal disease and dialysis on glycemic control. Semin Dial. 2000;13(1):4–8.CrossRefPubMed

41.

Kovesdy CP, Park JC, Kalantar-Zadeh K. Glycemic control and burnt-out diabetes in ESRD. Semin Dial. 2010;23(2):148–56.CrossRefPubMedPubMedCentral

42.

Hellman R. A systems approach to reducing errors in insulin therapy in the inpatient setting. Endocr Pract. 2004;10(Suppl 2):100–8.CrossRefPubMed

43.

Elliott MB, Schafers SJ, McGill JB, Tobin GS. Prediction and prevention of treatment-related inpatient hypoglycemia. J Diabetes Sci Technol. 2012;6(2):302–9.CrossRefPubMedPubMedCentral

44.

Farrokhi F, Klindukhova O, Chandra P, Peng L, Smiley D, Newton C, et al. Risk factors for inpatient hypoglycemia during subcutaneous insulin therapy in non-critically ill patients with type 2 diabetes. J Diabetes Sci Technol. 2012;6(5):1022–9.CrossRefPubMedPubMedCentral

45.

Maynard G, Lee J, Phillips G, Fink E, Renvall M. Improved inpatient use of basal insulin, reduced hypoglycemia, and improved glycemic control: effect of structured subcutaneous insulin orders and an insulin management algorithm. J Hosp Med. 2009;4(1):3–15.CrossRefPubMed

46.

•• Cobaugh DJ, Maynard G, Cooper L, Kienle PC, Vigersky R, Childers D, et al. Enhancing insulin-use safety in hospitals: practical recommendations from an ASHP Foundation expert consensus panel. Am J Health Syst Pharm. 2013;70(16):1404–13. This consensus paper provides practical recommendations to help ensure safe insulin use in hospitalized patients and minimize hypoglycemia.CrossRefPubMed

47.

Rubin DJ, Rybin D, Doros G, McDonnell ME. Weight-based, insulin dose-related hypoglycemia in hospitalized patients with diabetes. Diabetes Care. 2011;34(8):1723–8.CrossRefPubMedPubMedCentral

48.

Schafers S, Naunheim R, Vijayan A, Tobin G. Incidence of hypoglycemia following insulin-based acute stabilization of hyperkalemia treatment. J Hosp Med. 2012;7(3):239–42.CrossRefPubMed

49.

Curll M, Dinardo M, Noschese M, Korytkowski MT. Menu selection, glycaemic control and satisfaction with standard and patient-controlled consistent carbohydrate meal plans in hospitalised patients with diabetes. Qual Saf Health Care. 2010;19(4):355–9.CrossRefPubMed

50.

Boucher JL, Swift CS, Franz MJ, Kulkarni K, Schafer RG, Pritchett E, et al. Inpatient management of diabetes and hyperglycemia: implications for nutrition practice and the food and nutrition professional. J Am Diet Assoc. 2007;107(1):105–11.CrossRefPubMed

51.

Swift C. Nutrition therapy for the hospitalized and long-term care patient with diabetes. In: Franz M, Evert, A, editor. American Diabetes Association Guide to Nutrition Therapy for Diabetes. 2nd ed. Alexandria 2012. p. 229–45.

52.

Ojo O, Brooke J. Evaluation of the role of enteral nutrition in managing patients with diabetes: a systematic review. Nutrients. 2014;6(11):5142–52.CrossRefPubMedPubMedCentral

53.

Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(1):16–38.CrossRefPubMed

54.

Ryan DB, Swift CS. The mealtime challenge: nutrition and glycemic control in the hospital. Diabetes Spectr. 2014;27(3):163–8.CrossRefPubMedPubMedCentral

55.

Engle M, Ferguson A, Fields W. A journey to improved inpatient glycemic control by redesigning meal delivery and insulin administration. Clin Nurse Spec. 2016;30(2):117–24.CrossRefPubMed

56.

Institute for Safe Medication Practices. Acute care guidelines for timely administration of scheduled medication. 2011. Available from: http://www.ismp.org/tools/guidelines/acutecare/tasm.pdf.

57.

Kilpatrick CR, Elliott MB, Pratt E, Schafers SJ, Blackburn MC, Heard K, et al. Prevention of inpatient hypoglycemia with a real-time informatics alert. J Hosp Med. 2014;9(10):621–6.CrossRefPubMed

58.

Flory JH, Aleman JO, Furst J, Seley JJ. Basal insulin use in the non-critical care setting: is fasting hypoglycemia inevitable or preventable? J Diabetes Sci Technol. 2014;8(2):427–8.CrossRefPubMedPubMedCentral

59.

Mathioudakis N, Everett E, Golden SH. Prevention and management of insulin-associated hypoglycemia in hospitalized patients. Endocr Pract. 2016;22(8):959–69.CrossRefPubMed

60.

HK GSJ, Lipska KJ, Je B, Lin Z, Inzucchi SE. Blood glucose trends and prediction of severe hypoglycemia in hospitalized patients. San Diego: American Diabetes Association; 2011.

61.

Lee SY, Askin G, McDonnell ME, Arnold LM, Alexanian SM. Hypoglycemia rates after restriction of high-dose glargine in hospitalized patients. Endocr Pract. 2016;22(12):1393–400.CrossRefPubMed

62.

Maynard G, Stein J. Designing and implementing effective venous thromboembolism prevention protocols: lessons from collaborative efforts. J Thromb Thrombolysis. 2010;29(2):159–66.CrossRefPubMed

63.

Maynard GA, Morris TA, Jenkins IH, Stone S, Lee J, Renvall M, et al. Optimizing prevention of hospital-acquired venous thromboembolism (VTE): prospective validation of a VTE risk assessment model. J Hosp Med. 2010;5(1):10–8.PubMed

64.

Maynard G, Stein J. Preventing hospital-acquired venous thromboembolism: a guide for effective quality improvement Rockville 2008 Available from: http://www.ahrg.gov/qual/veguide/.

65.

Mendez CE, Ata A, Rourke JM, Stain SC, Umpierrez G. Daily inpatient glycemic survey (dings): a process to remotely identify and assist in the management of hospitalized patients with diabetes and hyperglycemia. Endocr Pract. 2015;21(8):927–35.CrossRefPubMed

66.

Rushakoff R, Sullivan M, MacMaster H, editors. The virtual inpatient glucose management service: improving glucose control and decreasing therapeutic inertia. San Francisco: The American Diabetes Association Scientific Sessions; 2014.

67.

Chapman JL, Lucas R, Lee J, Grimes SS, Porter AM, Bussey A. Implementation of inpatient blood glucose monitoring by clinical pharmacists. Am J Health Syst Pharm. 2013;70(17):1480–1.CrossRefPubMed

68.

Coats A, Marshall D. Inpatient hypoglycaemia: a study of nursing management. Nurs Prax N Z. 2013;29(2):15–24.PubMed

69.

Maynard G, Huynh M, Renvall M. Iatrogenic inpatient hypoglycemia: risk factors, treatment, and prevention analysis of current practice at an academic medical center with implications for improvement efforts. Diabetes Spectr. 2008;21(4):241–7.CrossRef

70.

Se SF, Tucker K. Hypoglycemia prevention: an innovative approach. Nursing. 2015;45(6):19–22.CrossRefPubMed

71.

De Alwis DT, Varadarajan S, Lim K. Notifying a doctor of a first hypoglycaemic episode is associated with a lower rate of recurrence among inpatients with diabetes. Med J Aust. 2014;200(2):79.CrossRefPubMed

72.

Ellis R. Hypoglycaemia monitoring in a medical receiving ward. BMJ Qual Improv Rep. 2015;4(1)

73.

MacEwen AW, Carty DM, McConnachie A, McKay GA, Boyle JG. A “diabetes acute care day” for medical students increases their knowledge and confidence of diabetes care: a pilot study. BMC Med Educ. 2016;16:88.CrossRefPubMedPubMedCentral

74.

Tamler R, Dunn AS, Green DE, Skamagas M, Breen TL, Looker HC, et al. Effect of online diabetes training for hospitalists on inpatient glycaemia. Diabet Med. 2013;30(8):994–8.CrossRefPubMed

75.

Tamler R, Green DE, Skamagas M, Breen TL, Lu K, Looker HC, et al. Durability of the effect of online diabetes training for medical residents on knowledge, confidence, and inpatient glycemia. J Diabetes. 2012;4(3):281–90.CrossRefPubMed

76.

Tamler R, Green DE, Skamagas M, Breen TL, Looker HC, LeRoith D. Effect of case-based training for medical residents on confidence, knowledge, and management of inpatient glycemia. Postgrad Med. 2011;123(4):99–106.CrossRefPubMed

77.

Wesorick DH, Grunawalt J, Kuhn L, Rogers MA, Gianchandani R. Effects of an educational program and a standardized insulin order form on glycemic outcomes in non-critically ill hospitalized patients. J Hosp Med. 2010;5(8):438–45.CrossRefPubMed

78.

Selig PM, Popek V, Peebles KM. Minimizing hypoglycemia in the wake of a tight glycemic control protocol in hospitalized patients. J Nurs Care Qual. 2010;25(3):255–60.CrossRefPubMed

Titel: How Low Can You Go? Reducing Rates of Hypoglycemia in the Non-critical Care Hospital Setting
verfasst von: Kristen Kulasa
Patricia Juang
Publikationsdatum: 01.09.2017
Verlag: Springer US
Erschienen in: Current Diabetes Reports / Ausgabe 9/2017
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI: https://doi.org/10.1007/s11892-017-0902-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

How Low Can You Go? Reducing Rates of Hypoglycemia in the Non-critical Care Hospital Setting

Abstract

Purpose of Review

Recent Findings

Summary

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2017

Can Cardiovascular Epidemiology and Clinical Trials Close the Risk Management Gap Between Diabetes and Prediabetes?

Remote Monitoring and Consultation of Inpatient Populations with Diabetes

Process-Based Treatment of Diabetes in Kaiser Permanente Southern California: How to Make Diabetes Care “Complete”

Why Are Diabetes Medications So Expensive and What Can Be Done to Control Their Cost?

Initial Weight Loss Response as an Indicator for Providing Early Rescue Efforts to Improve Long-term Treatment Outcomes

Use of Continuous Glucose Monitoring in Youth-Onset Type 2 Diabetes

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin